Theratechnologies Inc.

11:32 AM EST - Theratechnologies Inc. : Has reached an agreement with TaiMed Biologics, Inc. for the acquisition of the commercial rights to ibalizumab in the European Union, Israel, Norway, Russia and Switzerland. Theratechnologies Inc. shares T.TH are trading up $0.36 at $5.13.